| Literature DB >> 22163272 |
Christophe Hausswirth1, Julien Louis, François Bieuzen, Hervé Pournot, Jean Fournier, Jean-Robert Filliard, Jeanick Brisswalter.
Abstract
Enhanced recovery following physical activity and exercise-induced muscle damage (EIMD) has become a priority for athletes. Consequently, a number of post-exercise recovery strategies are used, often without scientific evidence of their benefits. Within this framework, the purpose of this study was to test the efficacy of whole body cryotherapy (WBC), far infrared (FIR) or passive (PAS) modalities in hastening muscular recovery within the 48 hours after a simulated trail running race. In 3 non-adjoining weeks, 9 well-trained runners performed 3 repetitions of a simulated trail run on a motorized treadmill, designed to induce muscle damage. Immediately (post), post 24 h, and post 48 h after exercise, all participants tested three different recovery modalities (WBC, FIR, PAS) in a random order over the three separate weeks. Markers of muscle damage (maximal isometric muscle strength, plasma creatine kinase [CK] activity and perceived sensations [i.e. pain, tiredness, well-being]) were recorded before, immediately after (post), post 1 h, post 24 h, and post 48 h after exercise. In all testing sessions, the simulated 48 min trail run induced a similar, significant amount of muscle damage. Maximal muscle strength and perceived sensations were recovered after the first WBC session (post 1 h), while recovery took 24 h with FIR, and was not attained through the PAS recovery modality. No differences in plasma CK activity were recorded between conditions. Three WBC sessions performed within the 48 hours after a damaging running exercise accelerate recovery from EIMD to a greater extent than FIR or PAS modalities.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22163272 PMCID: PMC3233540 DOI: 10.1371/journal.pone.0027749
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of runners.
| Variables (units) | Subjects (n = 9) |
| Age (years) | 31.8±6.5 |
| Height (m) | 1.79±0.06 |
| Weight (kg) | 70.6±6.5 |
| Training in running (sessions.week−1) | 4.8±1.3 |
| VO2max (ml.min−1.kg−1) | 62.0±3.9 |
| MAS (km.h−1) | 18.7±1.1 |
| V VT1 (km.h−1) | 14.2±0.7 |
| V VT2 (km.h−1) | 16.7±1.2 |
| 10 km personal best (hour:min:sec) | 00:34:48±00:02:35 |
| Semi-marathon personal best (hour:min:sec) | 01:17:12±00:06:12 |
| Marathon personal best (hour:min:sec) | 02:45:38±00:15:58 |
Data are means ± SD.
Legend Table 1: VO2max (ml.min−1.kg.−1), maximal oxygen consumption; MAS, maximal aerobic speed; V VT1 velocity at 1st ventilatory threshold; V VT2, velocity at 2nd ventilatory threshold.
Figure 1Schematic representation of the simulated running trail.
Flat, 0% gradient section; Up, +10% gradient section; Down, −15% gradient section.
Figure 2Recovery of knee extensor's maximal voluntary contraction (MVC, % of post), assessed after each of the three recovery sessions (post 1 h, post 24 h, post 48 h).
† significantly different from post condition (p<0.05), ‡ significantly different from post 1 h condition (p<0.05).
Indicators of exercise-induced muscle damage (EIMD), assessed before (pre) and after (post) the simulated running trail, and after the three recovery sessions (post 1 h, post 24 h, post 48 h).
| Variables (units) | Pre | Post | Post 1 h | Post 24 h | Post 48 h |
|
| |||||
|
| 0.0±0.0 | 40.5±18.4 | 44.2±20.9 | 192.3±179.3 | 107.5±121.1 |
|
| 0.0±0.0 | 58.2±18.9 | 73.9±33.4 | 318.9±224.7 | 195.3±141.6 |
|
| 0.0±0.0 | 56.4±25.1 | 63.7±26.5 | 231.8±132.1 | 137.6±99.8 |
|
| |||||
|
| 1.6±3.2 | 61.9±19.0 | 58.3±18.4 | 49.3±29.1 | 45.2±29.1 |
|
| 0.2±0.7 | 60.6±20.7 | 31.7±23.8 | 33.3±26.1 | 39.0±24.0 |
|
| 0.1±0.3 | 55.7±18.2 | 44.3±23.7 | 53.9±25.5 | 58.9±19.0 |
|
| |||||
|
| 8.3±9.8 | 75.3±11.2 | 67.8±21.3 | 65.8±20.0 | 61.8±15.9 |
|
| 5.2±9.8 | 77.9±13.3 | 44.6±26.3 | 35.9±19.4 | 46.6±24.0 |
|
| 8.7±12.3 | 65.4±26.6 | 52.2±27.0 | 49.2±21.4 | 60.7±26.7 |
|
| |||||
|
| 86.8±16.9 | 56.6±31.9 | 67.9±28.2 | 66.9±27.6 | 72.4±19.2 |
|
| 77.7±25.2 | 65.4±26.6 | 74.9±26.7 | 87.1±0.0 | 81.2±20.4 |
|
| 93.9±9.0 | 58.4±26.8 | 69.8±25.3 | 65.4±21.1 | 68.7±28.1 |
Data are means ± SD.
Legend Table 2: CK, plasmatic creatine kinase activity; FIR, far infrared; WBC, whole body cryotherapy; PAS, passive.
*significantly different from pre condition (p<0.05);
significantly different from post condition (p<0.05);
significantly different from post 1 h condition (p<0.05);
significantly different from post 24 h condition (p<0.05).